23 May 2013
Keywords: fda, approves, elan, zanaflex, spasticity, subsidiary, athena
Article | 09 December 1996
Elan subsidiary Athena Neurosciences has been granted approval by the
US Food and Drug Administration for its alpha-2 adrenoreceptor agonist
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 December 1996
6 January 1997
18 November 1996
© 2013 thepharmaletter.com